The major finding of our study is that of an inhibitory effect of minocycline and doxycycline on IFN-γ and IL-17 producing cells in a cell subset-related, dose-dependent manner in patients with MS, with the most prominent effect being noted in CD4+ T and NKT lymphocytes. Here, CD4 is linked to myeloid sarcoma.